SCHEMBL4481917

SCHEMBL4481917

CN1CCN(CC(=O)Nc2ccc(NC(=C3C(=O)Nc4cc(Cl)ccc43)c3ccccc3)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ GAA P10253 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ ATM Q13315 1/20 0.48
▸ POLB P06746 2/20 0.47
▸ GHSR Q92847 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ KCNA5 P22460 1/20 0.43
▸ ABCB1 P08183 1/20 0.43
▸ MAPT P10636 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ IDO1 P14902 1/20 0.42
▸ TDO2 P48775 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4481915 1.00 SMN1; SMN2 (0.55) SMN1; SMN2GAALMNAATMPOLB
SCHEMBL4504513 0.92 SMN1; SMN2 (0.56) SMN1; SMN2GAALMNAATMPOLB
SCHEMBL4504518 0.92 SMN1; SMN2 (0.56) SMN1; SMN2GAALMNAATMPOLB
SCHEMBL4482341 0.92 SMN1; SMN2 (0.51) SMN1; SMN2GAALMNAPOLBGHSR
SCHEMBL4482339 0.92 SMN1; SMN2 (0.51) SMN1; SMN2GAALMNAPOLBGHSR
SCHEMBL4493467 0.91 SMN1; SMN2 (0.56) SMN1; SMN2LMNAPOLBGHSRALDH1A1
SCHEMBL4493472 0.91 SMN1; SMN2 (0.56) SMN1; SMN2LMNAPOLBGHSRALDH1A1
SCHEMBL4488674 0.91 SMN1; SMN2 (0.56) SMN1; SMN2GAALMNAPOLBGHSR
SCHEMBL4503948 0.91 SMN1; SMN2 (0.56) SMN1; SMN2GAALMNAATMPOLB
SCHEMBL4488669 0.91 SMN1; SMN2 (0.56) SMN1; SMN2GAALMNAPOLBGHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 — — US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR SMN1; SMN2 4006/4885GAA 4394/4885LMNA 1884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback